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AbstrAct
Objectives Lay people or non-pharmacy health workers 
with training could dispense antiretroviral therapy (ART) 
in resource-constrained countries, freeing up time 
for pharmacists to focus on more technical tasks. We 
assessed the effectiveness of such task-shifting in low-
income and middle-income countries.
Method We conducted comprehensive searches of peer-
reviewed and grey literature. Two authors independently 
screened search outputs, selected controlled trials, extracted 
data and resolved discrepancies by consensus. We performed 
random-effects meta-analysis and assessed certainty of 
evidence using the Grading of Recommendations, Assessment, 
Development and Evaluation (GRADE) approach.
results Three studies with 1993 participants met the 
inclusion criteria, including two cluster trials conducted in 
Kenya and Uganda and an individually randomised trial 
conducted in Brazil. We found very low certainty evidence 
regarding mortality due to the low number of events. 
Therefore, we are uncertain whether there is a true increase 
in mortality as the effect size suggests, or a reduction in 
mortality between pharmacy and non-pharmacy models of 
dispensing ART (risk ratio (RR) 1.86, 95% CI 0.44 to 7.95, 
n=1993, three trials, very low certainty evidence). There may 
be no differences between pharmacy and non-pharmacy 
models of dispensing ART on virological failure (risk ratio (RR) 
0.92, 95% CI 0.73 to 1.15, n=1993, three trials, low certainty 
evidence) and loss to follow-up (RR 1.13, 95% CI 0.68 to 
1.91, n=1993. three trials, low certainty evidence). We found 
some evidence that costs may be reduced for the patient and 
health system when task-shifting is undertaken.
conclusions The low certainty regarding the evidence 
implies a high likelihood that further research may find 
the effects of the intervention to be substantially different 
from our findings. If resource-constrained countries decide 
to shift ART dispensing and distribution from pharmacy to 
non-pharmacy personnel, this should be accompanied by 
robust monitoring and impact evaluation.
bAckgrOund
Description of the condition
By March 2015, 15 million (40.7%) of the 
estimated 36.9 million people living with 
HIV (PLHIV) globally were receiving antiret-
roviral therapy (ART) in low-income and 
middle-income countries.1 Combination 
ART is effective for reducing HIV-related 
morbidity and mortality as well as preventing 
HIV transmission.2 Initiating ART early in the 
course of HIV infection has been associated 
with better health outcomes, both at patient 
and population levels.3 4 Scale up of ART in 
low-income and middle-income countries has 
averted more than 5 million deaths; however, 
bottlenecks preventing universal access to 
ART still exist. One challenge is the crit-
ical shortage of human resources for health 
(HRH), including for delivery of essential 
pharmacy services.
As for pharmacists, although the WHO 
recommends a minimum of one pharma-
cist per 2300 population,5 most countries in 
low-resource settings such as sub-Saharan 
Africa do not meet this target. In addition to 
the absolute shortage, it is likely that there 
is an uneven distribution of pharmacists in 
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Research
strengths and limitations of this study
 ► To our knowledge, this is the first published 
systematic review reporting the effects of task-
shifting from pharmacy to non-pharmacy personnel 
for dispensing or distributing antiretroviral therapy 
to patients living with HIV.
 ► The review was written according to the Preferred 
Reporting Items for Systematic Review and Meta-
Analysis  (PRISMA) Recommendations for reporting 
systematic reviews.
 ► The review findings may help to inform antiretroviral 
therapy guidelines by the WHO.
 ► A limitation of the review is paucity of evidence in 
this field and use of indirect evidence to inform our 
results.
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Table 1 Definitions and descriptions of dispensing and distribution of medications
Term Definition
Dispensing  ►Dispensing is a controlled act that authorises one to select, prepare and provide stock medication that has 
been prescribed to a patient or client (or his/her representative) for administration at a later time.29
 ►To dispense is to prepare and supply to a patient a course of therapy on the basis of a prescription.30
 ►Dispensing is preparation and distribution of a course of therapy to a patient, with appropriate instructions 
based on a prescription.30
Distribution  ►At facility level, drug distribution mainly refers to drugs dispensed by licenced practitioners, such as nurses, 
doctors, pharmacists or pharmacy assistants and collected by a patient.
 ►At community level, drug distribution refers to trained lay people collecting prepacked medications from the 
facility and delivering them to patients with HIV in the community.29
such settings, as is the case with other specialist health-
care workers who tend to concentrate in urban areas and 
the private sector, further aggravating the HRH shortage. 
For instance in South Africa, which is home to the largest 
number of PLHIV in any country worldwide, in 2010 
only 24% of registered pharmacists worked in the public 
sector where 80% of the population received care.6
description of the intervention
Studies and programmes report that involvement of phar-
macy personnel in HIV care results in improved patient 
outcomes.7 For instance, in the USA, the use of a multi-
disciplinary team approach with pharmacists assuming a 
central role in the initiation, dispensing and adherence 
counselling improved treatment outcomes such as viral 
load, patient retention and medication adherence.8
The work of pharmacists includes supply management, 
dispensing and distributing medications, promoting 
adherence, identifying and preventing potential medica-
tion-related issues (such as over dosage, subtherapeutic 
dosage, adverse drug reactions, medication errors and 
untreated indications) and monitoring and reporting 
adverse drug events.9 10 In some settings, programmes have 
implemented alternative models of pharmacy services 
that shift selected tasks from pharmacy to non-pharmacy 
personnel. Such alternative models could potentially 
increase the number of health workers involved in ART 
distribution, adherence counselling and patient educa-
tion; free more time for pharmacy personnel; support the 
integration of ART in primary care settings; minimise the 
number of facility visits for ART collection; and reduce 
pharmacy queue waiting times for patients.
The specifics of shifting ART-related tasks from phar-
macy personnel have not been addressed in a systematic 
review. Available systematic reviews on task-shifting focus 
on clinical services where nurses and non-physician 
clinicians provide care comparable with physicians.11 
We therefore synthesised the evidence for task-shifting 
in pharmacy personnel services, where non-pharmacy 
personnel undertake ART distribution and medication 
adherence counselling. Table 1 provides definitions for 
the pharmacy functions distribution and dispensing as 
they have been used in this review. However, these defini-
tions seem to overlap at facility level.
How task-shifting using non-pharmacy personnel might work
Within the last decade, several high HIV burden coun-
tries adopted task-shifting strategies where nurses and 
non-physician clinicians initiate and maintain ART. 
Although this has undeniably expanded access to ART, it 
is also increasingly essential that long facility waiting times 
and frequent facility visits to collect ART are addressed to 
alleviate the burden of care, both for patients and health-
care providers.9 10
Recent studies in Uganda, Kenya and Mozambique 
have shown positive outcomes when non-health profes-
sionals (lay people) delivered ART at the community 
level.12 In Mozambique, the use of PLHIV for distributing 
ART, monitoring adherence, reporting outcomes and 
referring sick patients to health facilities yielded a reten-
tion rate of 97.5% among stable patients on ART.12 In a 
cluster randomised trial in Uganda, the use of commu-
nity health workers produced comparable results with the 
facility-based ART programme in terms of patient reten-
tion, viral load suppression and mortality rate.13 Similar 
findings were also obtained in Kenya and some other 
parts of Uganda when lay providers were engaged in ART 
delivery.13 14
Task-shifting has therefore been seen as an achievable 
solution to the critical human resource shortages affecting 
scale up of ART.15 While it is imperative to increase the 
rate of recruitment and training of health workers as well 
as improve working conditions to reduce attrition and 
emigration, the HIV pandemic requires that all possible 
options are considered to address the critical skills 
shortage.16 Such measures may include shifting selected 
tasks from pharmacy to non-pharmacy personnel, partic-
ularly for patients stable on their ART. Task-shifting allows 
more time for pharmacy personnel to focus on more 
technical functions such as supply management, pharma-
covigilance and patient consultation.
Why this review is important
Dependence on and shortage of pharmacists are key 
constraints on ART expansion, but the specifics of 
task-shifting for ART distribution from pharmacy to 
non-pharmacy personnel have not been reviewed system-
atically. Previous systematic reviews of task shifting 
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for increasing ART access focused on clinical services 
where nurses and non-physician clinicians provide care. 
We systematically reviewed the scientific literature and 
assessed the efficacy of task-shifting models that use 
non-pharmacy and pharmacy personnel in distributing 
ART and assessing adherence to treatment of HIV infec-
tion.
Objective
This review evaluated the efficacy and safety of shifting 
pharmacy-related tasks, including ART distribution and 
adherence assessment, from pharmacy to non-pharmacy 
personnel.
MetHOds
The review was registered in PROSPERO Interna-
tional Prospective Register of Systematic reviews 
(http://www. crd. york. ac. uk/ PROSPERO), registration 
number CRD42015017034. The protocol as shown in 
online supplementary file 1 was published in the BMJ 
Open.17
criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) or observational 
studies with control arms conducted in low-income and 
middle-income countries.
Types of participants
PLHIV receiving ART.
Types of interventions
We included studies that evaluated shifting of selected 
tasks from pharmacy to non-pharmacy personnel. Tasks 
include distribution, dispensing of ART and adherence 
to ART as shown in table 1. Pharmacy personnel included 
pharmacists and pharmacy technicians, while non-phar-
macy personnel included patient peer groups, community 
volunteers, PLHIV, community health committees, nurses, 
physicians and non-physician clinicians.
Types of outcome measures
Primary outcome: mortality
Secondary outcomes: virological suppression; number of 
all-cause sick visits made to the health facility including 
adverse events; loss to follow-up; adherence to ART (as 
measured within the study, eg, pill counts, recall methods, 
digital methods, self report); acceptability to pharmacy 
personnel, non-pharmacy personnel and patients; and 
cost and harm including rates of errors.
search methods for identification of studies
We performed a comprehensive search of electronic data-
bases and conference proceedings to identify all relevant 
studies up until 10 May 2016, regardless of language of 
publication or publication status (published, unpub-
lished, in press and in progress). We searched Cochrane 
Central Register of Controlled Trials (CENTRAL), 
Excerpta Medica Database (Embase), PubMed, ISI Web 
of Science (Science Citation index) and WHO Global 
Health Library.
We used appropriate medical subject heading terms, 
relevant keywords and validated terms for identifying 
reports of RCTs.18 Search strategies are reported in table 2. 
We searched conference abstract archives of the Confer-
ence on Retroviruses and Opportunistic Infections, the 
International AIDS Conference and the International 
AIDS Society Conference on HIV Pathogenesis, Treat-
ment and Prevention, up to 10 May 2016. We contacted 
experts and organisations for additional studies.
data collection and analysis
Data collection and analysis approach was based on 
standards from the Cochrane Handbook of Systematic 
Reviews of Interventions.18
selection of studies for inclusion
Two review authors (NMM and OA) screened the 
titles and abstracts of all records to identify potentially 
eligible reports, and then independently inspected poten-
tially eligible publications for inclusion. Differences were 
discussed with a third author (CSW or TK) and resolved 
by discussion.
data extraction and management
Two review authors (NMM and OA) independently 
extracted data onto standardised, prepiloted data 
extraction forms. The following characteristics were 
extracted from each included study:
 ► Study details: citations of publications associated with 
the study, start and end dates, location, study design 
characteristics, type of facility involved, investigators, 
funding sources, recruitment, method of randomi-
sation, sequence generation, method of allocation 
concealment, blinding of participants and personnel, 
blinding of outcome assessors, length of follow-up, 
losses to follow-up, withdrawals or drop-outs and oth-
er relevant details.
 ► Details of the intervention: details of the cadre of 
health worker, what training or other support or su-
pervision they received and other relevant details.
 ► Details of participants: trial inclusion and exclusion 
criteria, numbers of participants entering the trial, 
sex, clinical staging, CD4 count and other pertinent 
details.
 ► Outcome details: definitions of outcomes, details of 
how outcomes were assessed, numerators and denom-
inators associated with each outcome, completeness 
of outcome data, effect estimates reported and other 
relevant outcome information.
Assessment of risk of bias in included controlled trials
Two review authors (NMM and OA) independently 
assessed the risk of bias in each study using the Cochrane 
Risk of Bias Tool, which measures risk of bias in controlled 
trials across seven domains: sequence generation, 
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Table 2 Search strategy for electronic databases
ID Search terms
PubMed
  #1 (task*[tiab] OR task-shifting[tiab] OR referr*[tiab] OR referral and consultation[mh] OR role*[tiab]) AND (health 
personnel[mh] OR doctor[tiab] OR doctors[tiab] OR clinician[tiab] OR clinicians[tiab] OR physician[tiab] OR 
physicians[tiab] OR ‘healthcare provider’[tiab] OR ‘healthcare providers’[tiab] OR ‘health care provider’[tiab] OR ‘health 
care providers’[tiab] OR pharmac*[tiab] OR apothecar*[tiab] OR chemist*[tiab] OR dispensar*[tiab])
  #2 randomiZed controlled trial[pt] OR controlled clinical trial[pt] OR randomiZed controlled trials[MeSH] OR random 
allocation[MeSH] OR double-blind method[MeSH] OR single-blind method[MeSH] OR clinical trial[pt] OR clinical 
trials[MeSH] OR (‘clinical trial’[tw]) OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw] OR tripl*[tw]) AND (mask*[tw] OR 
blind*[tw])) OR random*[tw] OR research design[mh:noexp] OR prospective studies[MeSH] OR control*[tw] OR 
volunteer*[tw]) OR observational[tw] OR non-random*[tw] OR nonrandom*[tw] OR before after study[tw] OR 
time series[tw] OR cohort*[tw] OR cross-section*[tw] OR prospective*[tw] OR retrospective*[tw] OR research 
design[mh:noexp] OR follow-up studies[MeSH] OR longitud*[tw] OR evaluat*[tiab] OR pre-post[tw] OR (pre-test[tw] 
AND post-test[tw]) NOT (animals[MeSH] NOT human[MeSH])
  #3 (HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tiab] OR hiv-1[tiab] OR hiv-2*[tiab] OR hiv1[tiab] OR hiv2[tiab] OR hiv 
infect*[tiab] OR HIV[tiab]OR human immune deficiency virus[tiab] OR human immuno-deficiency virus[tiab] OR human 
immune-deficiency virus[tiab] OR ((human immun*) AND (deficiency virus[tiab])) OR acquired immunodeficiency 
syndromes[tiab] OR acquired immune deficiency syndrome[tiab] OR acquired immuno-deficiency syndrome[tiab] 
OR acquired immune-deficiency syndrome[tiab] OR ((acquired immun*) AND (deficiency syndrome[tiab)]) or ‘sexually 
transmitted diseases, viral’[mh]) OR HIV[tiab] OR HIV/AIDS[tiab] OR HIV-infected[tiab] OR HIV[title] OR HIV/AIDS[title] 
OR HIV-infected[title]
  #4 (HAART[tiab] OR ART[tiab] OR cART[tiab] OR antiretroviral[tiab] OR anti-retroviral[tiab] OR anti-viral[tiab] OR 
antiviral[tiab] OR ‘Antiretroviral Therapy, Highly Active’[Mesh])
  #5 #1 AND #2 AND #3 AND #4
Scopus
(HIV OR HIV/AIDS OR AIDS OR ‘HUMAN IMMUNODEFICIENCY’ OR ‘ACQUIRED IMMUNODEFICIENCY’) AND TITLE-
ABS-KEY (TASK-SHIFTING OR TASKSHIFTING OR (TASK* AND SHIFT*) OR TASK* OR (REFERR* AND (NURSE* 
OR PHARMAC*))) AND TITLE-ABS-KEY (ANTIRETROVIRAL OR ANTI-RETROVIRAL OR ART OR CART OR HAART) 
AND TITLE-ABS-KEY (RANDOM* OR RANDOMIZED OR RANDOMISED OR TRIAL OR COHORT* OR GROUP* OR 
COMPAR* OR OBSERVATIONAL OR PROSPECTIVE* OR RETROSPECTIVE* OR ‘SYSTEMATIC REVIEW’ OR ‘META-
ANALYSIS’)
Web of Science
(TS=(HIV OR HIV/AIDS OR AIDS OR ‘HUMAN IMMUNODEFICIENCY’ OR ‘ACQUIRED IMMUNODEFICIENCY’) 
AND TS=(TASK-SHIFTING OR TASKSHIFTING OR (TASK* AND SHIFT*) OR TASK* OR (REFERR* AND (NURSE* OR 
PHARMAC*))) AND TS=(ANTIRETROVIRAL OR ANTI-RETROVIRAL OR ART OR CART OR HAART) AND TS=(RANDOM* 
OR RANDOMIZED OR RANDOMISED OR TRIAL OR COHORT* OR GROUP* OR COMPAR* OR OBSERVATIONAL OR 
PROSPECTIVE* OR RETROSPECTIVE* OR ‘SYSTEMATIC REVIEW’ OR ‘META-ANALYSIS’))
OR
(TI=(HIV OR HIV/AIDS OR AIDS OR ‘HUMAN IMMUNODEFICIENCY’ OR ‘ACQUIRED IMMUNODEFICIENCY’) 
AND TI=(TASK-SHIFTING OR TASKSHIFTING OR (TASK* AND SHIFT*) OR TASK* OR (REFERR* AND (NURSE* OR 
PHARMAC*))) AND TI=(ANTIRETROVIRAL OR ANTI-RETROVIRAL OR ART OR cART OR HAART) AND TI=(RANDOM* 
OR RANDOMIZED OR RANDOMISED OR TRIAL OR COHORT* OR GROUP* OR COMPAR* OR OBSERVATIONAL OR 
PROSPECTIVE* OR RETROSPECTIVE* OR ‘SYSTEMATIC REVIEW’ OR ‘META-ANALYSIS’))
CENTRAL
HIV* OR HIV-1* OR HIV-2* OR HIV1 OR HIV2 OR HIV INFECT* OR HUMAN IMMUNODEFICIENCY VIRUS OR HUMAN 
IMMUNEDEFICIENCY VIRUS OR HUMAN IMMUNE-DEFICIENCY VIRUS OR HUMAN IMMUNO-DEFICIENCY VIRUS 
OR HUMAN IMMUN* DEFICIENCY VIRUS OR ACQUIRED IMMUNEDEFICIENCY SYNDROME(AIDS) OR ACQUIRED 
IMMUNEDEFICIENCY SYNDROME OR ACQUIRED IMMUNO-DEFICIENCY SYNDROME OR ACQUIRED IMMUNE-
DEFICIENCY SYNDROME OR ACQUIRED IMMUN* DEFICIENCY SYNDROME in Title, Abstract, Keywords and (TASK-
SHIFTING OR TASKSHIFTING OR (TASK* AND SHIFT*) OR TASK* OR (REFERR* AND (NURSE* OR PHARMAC*))) 
in Title, Abstract, Keywords and ANTIRETROVIRAL OR ANTI-RETROVIRAL OR ART OR cART OR HAART in Title, 
Abstract, Keywords
WHO Global Health Library
(TASK-SHIFTING OR TASKSHIFTING OR (TASK* AND SHIFT*) OR TASK* OR (REFERR* AND (NURSE* OR PHARMAC*)) 
AND (HIV* OR human immunodeficiency) AND (antiretroviral OR anti-retroviral))) OR (HIV AND task-shifting) OR (HIV* 
AND task* AND shift*)
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allocation concealment, blinding of participants and 
personnel, blinding of outcome assessors, completeness 
of outcome data, selective outcome reporting and other 
potential biases.18
Measures of effect
We calculated and presented summary statistics for the 
risk ratio (RR) for dichotomous outcomes with their 95% 
CIs.
unit of analysis issues
The unit of analysis was the individual study participant 
for all the trials.
dealing with missing data
We contacted study authors for one of the included trials 
to obtain information on the composition of health 
professionals in the control groups involved in dispensing 
ART in order to establish whether pharmacy personnel 
were part of the team. However, the author no longer 
had those details but assumed that health professionals 
included pharmacy personnel.
Assessment of heterogeneity
We used the I2 statistic to measure heterogeneity among 
the trials. We planned to explore substantial hetero-
geneity (I2 >50%) by prespecified subgroup analysis. 
However, there was no evidence of serious heterogeneity.
Assessment of reporting biases
We minimised the potential for publication bias by 
using a comprehensive search strategy. As none of the 
meta-analysis include 10 or more studies, we did not 
assess publication bias using a funnel plot.18 19
data synthesis
Meta-analysis was conducted using Review Manager soft-
ware.20 We used a random effects model considering the 
diverse settings of the included studies. Where meta-anal-
ysis was not possible, for instance, for adherence and cost, 
a narrative synthesis of the evidence was carried out. We 
summarised the certainty of evidence for each outcome 
using Grading of Recommendations, Assessment, Devel-
opment and Evaluaton (GRADE).21 22 The GRADE system 
defines the certainty of evidence for each outcome as 
‘the extent of our confidence that the estimates of effect 
are correct’.18 The quality rating across studies has four 
levels: high, moderate, low or very low. Randomised trials 
are considered to be of high quality but can be down-
graded for any of the following five reasons: risk of bias; 
indirectness of evidence; unexplained heterogeneity or 
inconsistency of results; imprecision of results; and high 
probability of publication bias. Similarly, observational 
studies are considered to be of low quality but can be 
upgraded for any of these three reasons: large magni-
tude of effect; all plausible confounding would reduce a 
demonstrated effect; and the presence of a dose–response 
gradient. We independently considered the five factors 
for downgrading the evidence in included trials.
subgroup analysis and sensitivity analysis
Sensitivity analyses were not conducted to investigate the 
effect of excluding studies with high or low risk of bias 
due to the small number of studies included in the review. 
No subgroup analyses were indicated by the data.
results
A total of 3557 records were identified. Following title 
and abstract screening, eight studies were identified 
for full-text screening. Three trials met the inclusion 
criteria.14 23 24 The study selection process is shown in 
figure 1. The characteristics of included and excluded 
studies are shown in tables 3 and 4, respectively.
Overall, 1993 HIV-infected patients on ART were 
included. Of these, 1121 were assigned to non-pharmacy 
personnel model of ART delivery, while 872 were assigned 
to pharmacy personnel model of ART delivery.
Two studies14 23 included lay people in the non-phar-
macy personnel group, while the third24 included nurses 
in the non-pharmacy personnel group as shown in table 3.
risk of bias in included studies
All the included trials had low risk of selection bias as a 
result of adequate randomisation and allocation conceal-
ment. Selke et al14 and Jaffar et al23 were judged to have 
low risk of performance bias for blinding because the 
reported outcomes were objective and unlikely to be 
influenced by lack of blinding. However, the Selke trial14 
did not give sufficient information to permit judgement 
of whether detection bias was present. The Silveira trial24 
was judged to have a high risk of performance and 
detection bias due to lack of blinding for participants, 
personnel and outcome assessment respectively for all 
study outcomes. All trials have a low risk of attrition bias 
as they did not have differential or large numbers of 
losses to follow-up across the intervention arms. Selective 
reporting bias was judged to be low for the study by Jaffar 
et al23 and unclear for the Selke trial14 because the trial 
protocol was not available. The Silveira trial24 was judged 
as having unclear risk of reporting bias due to insufficient 
information and as having a high risk of other biases due 
to inadequate sample size. Figure 2 provides a graphical 
summary of the risk of bias assessments.
Mortality
There were six reported deaths across all three trials. 
When pooled, we found that there was very low certainty 
evidence regarding the effect of the task shifting from 
pharmacy to non-pharmacy personnel on death (RR 1.86; 
95% CI 0.44 to 7.95, figure 3), with no significant hetero-
geneity (χ2=3.34; df=2; p=0.19; I2=40%). We downgraded 
the quality of the evidence for indirectness because two of 
the three trials (Selke14 and Jaffar23) compared complex 
interventions that included, but were not limited to, phar-
macy and non-pharmacy personnel as shown in table 5. 
There were few deaths, and the effect estimate was 
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Figure 1 Flow diagram showing the search and selection of studies.
imprecise, with very wide CIs ranging from appreciable 
benefit to substantial harm.
Virological response
We found low certainty evidence that there may be no 
differences in virological failure between the group 
cared for by non-pharmacy personnel and that cared for 
by pharmacy personnel (RR 0.92; 95% CI 0.73 to 1.15, 
figure 4), with no heterogeneity (χ2=0.24; df=2; p=0.89; 
I2=0%). The quality of the evidence for this outcome was 
low due to serious indirectness and imprecision as shown 
in table 5.
loss to follow-up
We found low certainty evidence that there may be 
no difference in loss to follow-up between the groups 
(RR 1.13; 95% CI 0.68 to 1.91), with no heterogeneity 
(χ2=0.54; df=2; p=0.76; I2=0%), figure 5). The quality 
of the evidence was low due to serious indirectness and 
imprecision as shown in table 5.
clinic visits
Selke et al14 reported significantly more clinic visits in the 
pharmacy compared with the non-pharmacy personnel 
group (mean visits 12.6 vs 6.4), p<0.001. Although the 
non-pharmacy personnel group was found to have fewer 
clinic visits, the authors observed that this group attended 
64% more clinic visits than originally scheduled. The study 
by Jaffar et al23 found a high frequency of outpatient atten-
dance (15 242 visits) in the pharmacy compared with the 
non-pharmacy personnel group (6691 visits). However, 
they found similar distribution of new diagnoses between 
groups where more than 50% were infectious and para-
sitic infections. The trial by Silveira et al24 did not report 
on clinic visits.
Incidence of opportunistic infections
Selke14 trial reported an incidence of 13.6 HIV opportu-
nistic infections per 100 person-years in the non-pharmacy 
personnel group compared with 19.8 HIV opportu-
nistic infections per 100 person-years in the pharmacy 
personnel group.
Adherence
All trials reported similar high-level adherence using 
different measures.
cost
In the trial by Jaffar et al,23 a societal perspective economical 
analysis showed a higher mean cost per patient per year in 
the pharmacy personnel group ($838) for health services 
(staff, transport, drugs, laboratory and clinical services, 
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Table 4 Summary of excluded studies
Study ID Reasons for exclusion
March et al31 All participants were enrolled in the pharmacist-managed HIV drug optimisation clinic, with 
no non-pharmacist control group. We excluded this study because we could not make the 
comparisons due to the absence of a non-pharmacy personnel group.
Chang et al32 Non-pharmacy personnel did not dispense or distribute ART.
Kiweewa et al33 Dispensing of ART done in same way for both groups, hence we could not make comparisons.
Hansudewechakul et al34 Cohort study with comparisons between community and non-community hospitals with both 
groups having pharmacy personnel.
Henderson et al35 Observational study with no comparison group.
ART, antiretroviral therapy.
Figure 2 Summary of risk of bias in included studies.
sensitisation, training and workshops, utilities, supervi-
sion and overhead capital) compared with non-pharmacy 
personnel group ($793). Similarly, total per patient costs to 
access care per year was higher in the pharmacy personnel 
group ($54) compared with non-pharmacy personnel 
group ($18). Costs to access care included transport, lunch, 
childcare and lost work time. The outcome cost was not 
prespecified in the protocol; however, this provides addi-
tional data that may be relevant for decision makers and was 
therefore included for consideration.
Acceptability to pharmacy personnel, non-pharmacy 
personnel and patients and harm, including error rates.
These outcomes were not reported in the included trials.
dIscussIOn
Summary of main results
Two cluster randomised clinical trials and one non-blinded 
RCT were included in this review of effects of shifting 
responsibility from pharmacy to non-pharmacy personnel 
for adherence assessment and dispensing antiretroviral 
drugs to patients with HIV.
In our meta-analysis, we found very low certainty evidence 
for the outcome mortality. We are therefore not certain 
whether the intervention may impact on mortality or not. 
We found low certainty evidence that there may be no 
difference in virological response and loss to follow-up 
between non-pharmacy personnel and pharmacy personnel 
distributing ART to patients. In addition, we did not find 
significant differences in adherence to treatment. Selke et 
al14 report that the non-pharmacy personnel group had 
significantly fewer all-cause sick visits to the clinic compared 
with the pharmacy personnel group. Although the main 
difference between the Selke14 and Jaffar23 trials was the 
level of education of the non-pharmacy personnel, it did 
not seem to affect their overall performance.14 23
Additionally, the Jaffar trial23 found the non-pharmacy 
dispensing strategy to be cost-effective and cheaper to run 
than the pharmacy dispensing strategy by almost US$45 
per patient per annum, and this accounted for only 6% 
of the total cost of healthcare service expenditure for the 
intervention group.23 The patients who were accessing 
their medications and other healthcare services from 
pharmacy personnel incurred more costs in terms of 
transportation, lunch, childcare costs and lost work time. 
In the first year of the study, the pharmacy personnel 
group incurred double the cost of healthcare services 
per patient per annum compared with the non-pharmacy 
personnel group. This is a challenge in most poor settings 
in Africa where many cannot afford basic necessities, and 
this further impedes their access to treatment.23 Lack of 
or inadequate financial resources are major factors in late 
presentation to health facilities, poor access to HIV care 
and support and low retention in care after initiation of 
ART.25 26 Although health services are provided for free in 
most public institutions, the cost of accessing the services 
may serve as a hindrance to achieving optimal care and 
support for HIV-infected patients.25 The non-pharmacy 
personnel dispensing ART may reduce the cost of services 
for both patients and governments with potentially favour-
able clinical outcomes.
Although issues related to drug–drug interaction, medi-
cation errors, prescreening for ART and some special cases 
of adherence to therapy may be beyond the capacity of 
non-pharmacy personnel, targeted pharmacy support to 
non-pharmacy personnel could offer benefits to patients 
having challenges with their medications especially those 
who are taking concomitant medications with ART.27
This review and meta-analysis has shown that the use of 
non-pharmacy personnel comprising either lay people or 
other health professionals such as nurses who are given 
well-tailored and comprehensive short trainings with 
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Figure 3 Effect of shifting dispensing of antiretroviral therapy (ART) from pharmacy to non-pharmacy personnel on mortality.
Table 5 GRADE summary of findings table for pharmacy versus non-pharmacy personnel for dispensing antiretroviral therapy
Population: people living with HIV
Setting: Brazil, Kenya and Uganda (one study per country)
Intervention: non-pharmacy personnel for dispensing antiretroviral therapy
Control: pharmacy personnel for dispensing antiretroviral therapy
Outcomes
(mean follow-up: 
12 months)
Pharmacy 
personnel
Non-pharmacy 
personnel
Relative effect
(95% CI)
No. of Participants
(studies)
Quality of evidence
(GRADE)
Mortality 76 per 1000 141 per 1000
(33 to 602)
RR 1.86
(0.44 to 7.95)
1993
(three studies)
⊕⊕⊕⊝
very low1 2
Virological failure 131 per 1000 120 per 1000
(95 to 150)
RR 0.92
(0.73 to 1.15)
1993
(three studies)
⊕⊕⊝⊝
low1 3
Loss to follow-up 28 per 1000 31 per 1000
(19 to 53)
RR 1.13
(0.68 to 1.91)
1993
(three studies)
⊕⊕⊝⊝
low1 3
GRADE Working Group grades of evidence.
High certainty: further research is very unlikely to change our confidence in the estimate of effect.
Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may change the 
estimate.
Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the 
estimate.
Very low certainty: we are very uncertain about the estimate.
*We downgraded by one for serious indirectness: Two trials compared complex interventions that included, but were not merely limited to, 
pharmacy and non-pharmacy personnel.
†We downgraded by two for serious imprecision: There are few events and the effect estimates have wide confidence intervals, ranging from 
appreciable benefit to harm.
‡We downgraded by one for serious imprecision: there are few events, and the effect estimates have wide CIs, ranging from appreciable 
benefit to harm.
GRADE, Grading of Recommendations, Assessment, Development and Evaluaton; RR, risk ratio.
refreshers may be able to support ART dispensing systems 
for patients with HIV; however, the low certainty evidence 
implies that additional trial evidence may change our 
results. The use of non-pharmacy personnel such as lay 
people for dispensing ART and monitoring patients’ 
health would enable identification of psychosocial 
features that might be overlooked by physicians, nurses 
and pharmacists at the facility. Some of these psychosocial 
problems such as gender-based violence, food insecu-
rity and alcohol abuse negatively impact on adherence 
and retention in care.14 In the case of community-based 
non-pharmacy personnel, they could also serve as a link 
between the patients and other healthcare workers and 
facilitate smooth communication between the patients 
and the pharmacists on issues such as changes in regimen 
and dosage of drugs.14 27
Overall completeness and applicability of evidence
Although it may not be possible to rule out publication 
and language biases in systematic reviews, our electronic 
search was not restricted to language, setting or publica-
tion status.
We identified three studies for inclusion with small 
sample sizes and event rates. The trials did not specifi-
cally pose the question of task-shifting to non-pharmacy 
personnel and included this approach within complex 
interventions. As such, this provides indirect evidence 
where other aspects of the intervention may have resulted 
in the outcomes reported. The trials did not include 
some of the outcomes of interest for decision making 
such as acceptability to participants and feasibility of the 
intervention. These limitations might have affected our 
conclusions about the findings from these trials.
certainty of evidence
We assessed the certainty of evidence using the GRADE 
approach.28 Evidence from this review should be applied 
with caution considering its very low and low quality. 
We are therefore not confident enough to state that the 
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Figure 4 Effect of shifting dispensing of antiretroviral therapy (ART) from pharmacy to non-pharmacy personnel on virological 
failure.
Figure 5 Effect of shifting dispensing of antiretroviral therapy (ART) from pharmacy to non-pharmacy personnel on loss to 
follow-up.
estimates lie close to the true value, and it is likely that 
further studies would contribute to the body of knowl-
edge to inform these results.
cOnclusIOns
There is low certainty evidence that loss-to-follow up and 
virological outcomes may be the same whether pharmacy 
or non-pharmacy personnel provide services to PLHIV on 
ART in resource-limited settings. This is particularly when 
accompanied by continued capacity building and super-
vision by trained pharmacy personnel. However, there 
is very low certainty evidence regarding the mortality 
outcome where further evidence will impact the result. 
The use of non-pharmacy personnel including lay people 
in dispensing and distributing ART may be cost-effective 
for the patient and health system. Strong referral systems 
are crucial in task-shifting of dispensing responsibilities to 
non-pharmacy personnel to support patients that require 
advanced medical attention. Due to the critical shortage 
of human personnel in the health sector, most HIV 
programmes engaged other cadres of health personnel 
other than doctors to prescribe and dispense ART at the 
onset of their programme implementation. This might 
have contributed to scarcity of studies on the use of phar-
macy personnel for dispensing and distributing ART. 
More trials, with adequate sample sizes to detect clinically 
relevant health benefits, are therefore needed to inves-
tigate task-shifting of dispensing and distributing ART 
from pharmacy to non-pharmacy personnel. Programmes 
considering implementation of task-shifting should do 
so with inclusion of close monitoring and evaluation for 
health and process outcomes.
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